158 related articles for article (PubMed ID: 18086970)
21. Toll-like receptors 4 contribute to endothelial injury and inflammation in hemorrhagic shock in mice.
Benhamou Y; Favre J; Musette P; Renet S; Thuillez C; Richard V; Tamion F
Crit Care Med; 2009 May; 37(5):1724-8. PubMed ID: 19325486
[TBL] [Abstract][Full Text] [Related]
22. Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4.
Klein M; Obermaier B; Angele B; Pfister HW; Wagner H; Koedel U; Kirschning CJ
J Infect Dis; 2008 Oct; 198(7):1028-36. PubMed ID: 18700834
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
[TBL] [Abstract][Full Text] [Related]
24. Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft.
Tamura S; Ouchi KF; Mori K; Endo M; Matsumoto T; Eda H; Tanaka Y; Ishitsuka H; Tokita H; Yamaguchi K
Clin Cancer Res; 1995 Nov; 1(11):1353-8. PubMed ID: 9815931
[TBL] [Abstract][Full Text] [Related]
25. Systemic inflammation and end organ damage following trauma involves functional TLR4 signaling in both bone marrow-derived cells and parenchymal cells.
Mollen KP; Levy RM; Prince JM; Hoffman RA; Scott MJ; Kaczorowski DJ; Vallabhaneni R; Vodovotz Y; Billiar TR
J Leukoc Biol; 2008 Jan; 83(1):80-8. PubMed ID: 17925504
[TBL] [Abstract][Full Text] [Related]
26. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis.
Hodgkinson CP; Laxton RC; Patel K; Ye S
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2275-81. PubMed ID: 18818414
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoid blockade does not abrogate tumor-induced cachexia.
Rivadeneira DE; Naama HA; McCarter MD; Fujita J; Evoy D; Mackrell P; Daly JM
Nutr Cancer; 1999; 35(2):202-6. PubMed ID: 10693176
[TBL] [Abstract][Full Text] [Related]
28. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM
Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of the nicotine antiinflammatory pathway improves food intake and body composition in tumor-bearing rats.
Molfino A; Logorelli F; Citro G; Bertini G; Ramaccini C; Bollea MR; Rossi Fanelli F; Laviano A
Nutr Cancer; 2011; 63(2):295-9. PubMed ID: 21298590
[TBL] [Abstract][Full Text] [Related]
30. Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria.
Ragnarsdóttir B; Samuelsson M; Gustafsson MC; Leijonhufvud I; Karpman D; Svanborg C
J Infect Dis; 2007 Aug; 196(3):475-84. PubMed ID: 17597463
[TBL] [Abstract][Full Text] [Related]
31. The influence of age and sex on disease development in a novel animal model of cardiac cachexia.
Palus S; Akashi Y; von Haehling S; Anker SD; Springer J
Int J Cardiol; 2009 Apr; 133(3):388-93. PubMed ID: 19246111
[TBL] [Abstract][Full Text] [Related]
32. Role played by Toll-like receptors 2 and 4 in lipoteichoic acid-induced lung inflammation and coagulation.
Dessing MC; Schouten M; Draing C; Levi M; von Aulock S; van der Poll T
J Infect Dis; 2008 Jan; 197(2):245-52. PubMed ID: 18179383
[TBL] [Abstract][Full Text] [Related]
33. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
34. Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors.
Murata M
Cancer Sci; 2008 Jul; 99(7):1435-40. PubMed ID: 18452561
[TBL] [Abstract][Full Text] [Related]
35. Role of Toll-like receptor 4 in innate immune responses in a mouse model of acute otitis media.
Hirano T; Kodama S; Fujita K; Maeda K; Suzuki M
FEMS Immunol Med Microbiol; 2007 Feb; 49(1):75-83. PubMed ID: 17266713
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning.
Pradillo JM; Fernández-López D; García-Yébenes I; Sobrado M; Hurtado O; Moro MA; Lizasoain I
J Neurochem; 2009 Apr; 109(1):287-94. PubMed ID: 19200341
[TBL] [Abstract][Full Text] [Related]
37. Molecular or pharmacologic inhibition of the CD14 signaling pathway protects against burn-related myocardial inflammation and dysfunction.
Barber RC; Maass DL; White DJ; Chang LY; Horton JW
Shock; 2008 Dec; 30(6):705-13. PubMed ID: 18461018
[TBL] [Abstract][Full Text] [Related]
38. Rho proteins are negative regulators of TLR2, TLR3, and TLR4 signaling in astrocytes.
Borysiewicz E; Fil D; Konat GW
J Neurosci Res; 2009 May; 87(7):1565-72. PubMed ID: 19115402
[TBL] [Abstract][Full Text] [Related]
39. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
40. Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression.
Hodgkinson CP; Ye S
Pharmacogenet Genomics; 2008 Sep; 18(9):803-13. PubMed ID: 18698233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
